2018 was a historic year for initial public offerings (IPOs) on the stock market. In fact, there are many successful companies that had their IPO in 2018. And as an investor, there is much to learn from and reflect on. Therefore, lets take a closer look at some of the standout IPOs that made their public debuts in 2018.
2018 was full of newsworthy events around the globe. In the United States, there was marijuana reform, gun control protests and a partial government shutdown in December.
There were many monumental moments in other parts of the world as well. In sports, there was the Winter Olympics in February and the World Cup in July. Meghan Markle became the first woman of color to join the British Royal Family. Cuba ended the 59-year reign of Castro leadership, announcing Miguel Diaz-Canel as its new President. And North and South Korea vowed to formally end the Korean War.
However, the stock market had one of its worst years in over a decade. Specifically, the S&P 500 was down 6.2%. The Dow fell 5.6% and the Nasdaq dropped 4%. But there were many companies that had their IPO in 2018 nonetheless. And some have brought in massive returns since their offering dates. For example, five of the best IPOs in 2018 include:
Each of these stocks is flourishing on the market since making its public debut in 2018. And this comes despite the recent stock market downturn, recession fears and high inflation. Thats why I consider them a few of the best companies that had their IPO in 2018. Therefore, lets dig into their stock performances a little further.
Americold provides supply chain services and infrastructure for food service providers, retailers, producers and direct-to-consumer. In addition, Americold has 249 facilities around the globe.
COLD stock made its debut on the New York Stock Exchange (NYSE) on January 19, 2018 for $724.8 million at $17 per share. In just four years time, its now trading around $30 a share with an all-time high closing of $39.21 in July of 2021. Since its offering date, Americold stock is up more than 70%.
BJs is a popular membership-only warehouse club chain that operates on the East Coast of the United States with plans to expand in the near future. Its main competitors includeCostco (Nasdaq: COST) and Sams Club, which is owned and operated by Walmart (NYSE: WMT).
While BJs is much smaller, it has become a stock market darling since its debut. The IPO came on June 28, 2018 for $733.13 million at $17 a share. The stock is now trading around $70 for an increase of more than 300% since its IPO. Furthermore, its one of the few companies that is up year-to-date (YTD) at close to 7% despite the bear market. BJs is clearly one of the best companies that had their IPO in 2018 based on performance alone.
Moderna is a pioneer in delivering transformative medicines and vaccines via mRNA science. And as you may know, it produces one of the most prominent COVID-19 vaccines and booster shots. Moderna has played a major role in the fight against COVID-19 and will continue to do so moving forward.
Before the pandemic, Moderna went public on December 7, 2018 for $23.00 a share. Its now trading for more than $170! Thats an increase of close to 630% since its IPO.
Nio is an electric vehicle company out of China. Its currently producing six EV car models, home charging equipment, battery swaps and mobile charging services. The ES6, a five-seater mid-size SUV, seems to be its flagship model with close to half of its sales in a record-breaking June.
Nio launched on the NYSE for $6.26 per share on September 12, 2018. Its now trading just below $20 a share, though it hit an all-time high of $66.90 in January of 2021. As you can see, Nio has the potential as one of the best companies that had their IPO in 2018.
Twist Bioscience is a biotech company in San Francisco that manufactures synthetic DNA and DNA products for various industries. These DNA tools help research in human genetics, drug discovery, infectious diseases, animal health and more.
The Twist Bioscience IPO hit the market on October 30, 2018 for $14 per share. In 2022, TWST stock is pushing $50. However, it was trading close to $200 per share in 2021 before a drastic decline that winter.
While 2018 wasnt the best of years in terms of the overall stock market, many businesses shined in their debuts. The five stocks above continue to impress in difficult circumstances as volatility continues to rise.
As the market fights to recover, its important that you continue to do your due diligence and expand your research even further. Consider signing up for one of the best investment newsletters. These daily e-letters give readers stock insights, chart analysis and trends that may help you make better investment decisions.
Its also wise to learn more about the IPO process before investing in new offerings. This step-by-step guide breaks down everything you need to know.
You may have missed out on the massive returns of some of the best companies that had their IPO in 2018. However, you can position yourself to take advantage of future gains by staying on top of the market and scouring news feeds, analyzing chart patterns and doing extensive research.
Corey Mann is the Content Manager of Investment U. He has more than 10 years of experience as a journalist and content creator. Since 2012, Coreys work has been featured in major publications such as The Virginian-Pilot, The Washington Post, CNN, MSNBC and more. When Corey isnt focusing on Investment U, he enjoys traveling with his wife, going to Yankees games and spending time with his family.
Go here to read the rest:
Revisiting Companies That Had Their IPO in 2018 - Investment U
- 1st draft of a human 'pangenome' published, adding millions of ... - May 17th, 2023
- A Brief Guide to Genomics - National Human Genome Research Institute - May 17th, 2023
- Human genetics - Immunogenetics | Britannica - April 23rd, 2023
- A Troublesome Inheritance - Wikipedia - April 23rd, 2023
- Human - Simple English Wikipedia, the free encyclopedia - January 29th, 2023
- Human Genetics and Genomics Training Program - Hopkins Medicine - January 4th, 2023
- Genetics vs. Genomics Fact Sheet - Genome.gov - December 18th, 2022
- Human Genetics and Molecular Biology, PhD - Johns Hopkins University - December 18th, 2022
- Race (human categorization) - Wikipedia - December 2nd, 2022
- Human Y-chromosome DNA haplogroup - Wikipedia - November 24th, 2022
- Abstracts | International Congress of Human Genetics 2023 - November 24th, 2022
- Human genetic variation - Wikipedia - November 6th, 2022
- Genetics | The Smithsonian Institution's Human Origins Program - October 29th, 2022
- Fluent BioSciences showcasing breakthrough solutions to enable unprecedented scale, cost-efficiency and access for single-cell RNA sequencing at the... - October 29th, 2022
- Researchers seek to unravel the mystery of susceptibility to drug addiction - Newswise - October 4th, 2022
- NIH initiative to systematically investigate and establish function of every human gene - National Institutes of Health (.gov) - October 4th, 2022
- ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma | Communications Biology - Nature.com - October 4th, 2022
- Does obesity have more to do with the brain than we initially thought? - Medical News Today - October 4th, 2022
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 4th, 2022
- Solving medical mysteries: Physicians and researchers collaborate to study the most challenging cases - AAMC - October 4th, 2022
- Mystery gene matures the skeleton of the cell - EurekAlert - October 4th, 2022
- What Is The Most Important factor Driving The Global Human Genetics Market? - PharmiWeb.com - September 25th, 2022
- How Africa's genetic diversity can be harnessed to close the continent's 'drug and treatment gap' - Genetic Literacy Project - September 25th, 2022
- Ability to move to the pulse of music has genetic link - DTNEXT - September 25th, 2022
- Is the Spike Protein Changing Our Gene Expression? - The Epoch Times - September 25th, 2022
- How prehistoric DNA is helping to unlock the secrets of human evolution - EL PAS USA - September 25th, 2022
- Personalised medicine and the advantages of big data and AI-based diagnostics - Medical Device Network - September 25th, 2022
- Viewpoint: In the post Roe v Wade world, what changes should a biology textbook writer make to address the medical repercussions of Dobbs? - Genetic... - September 25th, 2022
- Bears' ability to regulate insulin narrowed down to eight proteins WSU Insider - WSU News - September 25th, 2022
- Sex, Selection and Biodiversity - Syracuse.edu - Syracuse University - September 25th, 2022
- Was the Russian Flu the first coronavirus pandemic? Find out at next Science Caf - University of Nebraska at Kearney - September 25th, 2022
- University of Chicago South Side Science Fest created to show off the fun, myriad pathways into field. - Chicago Tribune - September 25th, 2022
- The genetics of human personality - PubMed - August 14th, 2022
- Genetics - The Harvey Institute for Human Genetics - GBMC HealthCare in ... - August 14th, 2022
- Degrees of the Future 2022: Genetics - Gizmodo - August 14th, 2022
- U of U Health-Led Research Awarded $28 Million to Explore HIV's Inner Workings and Vulnerabilities - University of Utah Health Care - August 14th, 2022
- Monkeypox Myth Busting: Here's What You Need to Know - The Mighty - August 14th, 2022
- Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights - Yahoo Finance - August 5th, 2022
- Baylor receives NCI grant to study liver cancer risk and prevention - Baylor College of Medicine News - August 5th, 2022
- Whole Exome Sequencing Market reach a valuation of US$ 4,256.30 Mn, at a CAGR of 19.24% in the Forecast 2030 - BioSpace - August 5th, 2022
- Mendels Genetic Revolution and the Legacy of Scientific Racism - NewsClick - August 5th, 2022
- AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH - BioSpace - August 5th, 2022
- Cotton Buds Market Value Is Estimated to Reach USD 747.16 BN By 2028, With 3.2% CAGR Credence Research - Digital Journal - August 5th, 2022
- Verve Therapeutics Shares Up 84%; ARKG Offers Exposure - ETFdb.com - July 27th, 2022
- Double up on the guac? Those avocados are good for your heart health - American Heart Association - July 27th, 2022
- Extending the PAX1 spectrum: a dominantly inherited variant causes oculo-auriculo-vertebral syndrome | European Journal of Human Genetics - Nature.com - July 27th, 2022
- Scientists Unravel the Mystery of Junk Genes That Are Key to Brain Development - SciTechDaily - July 27th, 2022
- COVID-19 Can Make the Brain Age by 2 Decades; Here's 1 Way to Reverse Aging - The Epoch Times - July 27th, 2022
- Mice Model Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Service, Technology, Indication, End User, Application, and Mode -... - July 27th, 2022
- Master's Degree in Human Genetics | Human Genetics | Michigan Medicine ... - July 11th, 2022
- Here's how the $100 Human Genome will Change Medicine - BioSpace - July 11th, 2022
- Genomic medicine: the role of the nursing workforce - Nursing Times - July 11th, 2022
- AbbVie Half Breaks Up with Alector on Alzheimer's - BioSpace - July 11th, 2022
- The human identification market size is projected to reach - GlobeNewswire - July 11th, 2022
- Global wheat production can be doubled to feed millions and save land, say scientists - Sky News - July 11th, 2022
- Huntsville native among TIMEs 100 most influential people - WHNT News 19 - July 3rd, 2022
- New hope for IVF patients as global study published in Human Reproduction shows AI can effectively assess genetic integrity of embryos - Yahoo Finance - July 3rd, 2022
- A Week At The Most Secretive Conference On Aging - Forbes - July 3rd, 2022
- Human genetics shape the gut microbiome - PMC - June 13th, 2022
- expert reaction to a conference abstract on retinal screening predicting risk of myocardial infarction - Science Media Centre - June 13th, 2022
- New Comprehensive Map Ties Every Human Gene to Its Function - SciTechDaily - June 13th, 2022
- Buffalo shooters manifesto quoted a university researcher. Thats raising questions about racism in academia - Yahoo News - June 13th, 2022
- Thalidomide could be used as a therapeutic for AVMs - Cosmos - June 13th, 2022
- How Electric Fish Were Able to Evolve Electric Organs - UT News - University of Texas - June 4th, 2022
- Survival of the Best: The Past, Present and Future of Plants - CSRwire.com - June 4th, 2022
- AMGEN ANNOUNCES WEBCAST OF 2022 JEFFERIES HEALTHCARE CONFERENCE | News | wfmz.com - 69News WFMZ-TV - June 4th, 2022
- Experts Discover New Disease Caused by Faulty Genes Affecting the Kidney and Liver: Newcastle University Study - Nature World News - June 4th, 2022
- At-Home Colorectal Cancer Testing and Follow-Up Vary by Ethnicity - Medscape - June 4th, 2022
- Who is your real parent? Our Father on Netflix depicts the dark side of 'secret serial sperm donation'. My birth has a similar origin but with a more... - June 4th, 2022
- Autism and the complete human genome: Q&A with Evan Eichler | Spectrum - Spectrum - May 15th, 2022
- Increased Mutations in Children Can Be Traced Back to Mistakes in Father's Sperm - Neuroscience News - May 15th, 2022
- Not All Is Rosy For The Pink Pigeon - Eurasia Review - May 15th, 2022
- Why haven't we cloned a human yet? - Livescience.com - May 15th, 2022
- Study probes the relationship between genetics, proteins, and disease risk - The Hub at Johns Hopkins - May 15th, 2022
- Singular Genomics Announces Formation of Scientific Advisory Board - BioSpace - May 15th, 2022
- COVID Resistance Might Be Tied To Genetics: Experts - Medical Daily - May 15th, 2022
- Letter: Why no to Roe and abortion - INFORUM - May 15th, 2022
- Gut Microbiome Composition Predictive of Patient Response to Statins - Business Wire - May 15th, 2022
- Finding A Place In Science - Texas A&M Today - Texas A&M University Today - May 15th, 2022
- Parag Agrawals wife Vineeta linked with Musks Twitter takeover - The Siasat Daily - May 15th, 2022